Compare Moderna, Inc. (MRNA) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs SoFi Technologies Inc — how do they compare? Moderna, Inc. trades at $60.53 (market cap $24.18B), while SoFi Technologies Inc trades at $18.08 (market cap $23.22B). The key difference: Moderna, Inc. and SoFi Technologies Inc are close in size by market cap, and Moderna, Inc. is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | SOFI | |
|---|---|---|
Market Cap | $24.18B | $23.22B |
Sector | Health | Financials |
52-Week High | $81.80 | $32.21 |
52-Week Low | $22.36 | $15.15 |
Enterprise Value | $20.33B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
